Amarin Corp. Plc (AMRN)
13.88
0.00 (0.00%)
USD |
NASDAQ |
Sep 01, 16:00
13.88
0.00 (0.00%)
After-Hours: 20:00
Amarin Cash from Operations (TTM) : 15.55M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 15.55M |
| March 31, 2026 | 25.63M |
| December 31, 2025 | 6.744M |
| September 30, 2025 | -21.82M |
| June 30, 2025 | -11.50M |
| March 31, 2025 | -30.95M |
| December 31, 2024 | -31.03M |
| September 30, 2024 | -18.44M |
| June 30, 2024 | -8.645M |
| March 31, 2024 | 1.384M |
| December 31, 2023 | 6.907M |
| September 30, 2023 | 7.353M |
| June 30, 2023 | -17.34M |
| March 31, 2023 | -88.77M |
| December 31, 2022 | -179.98M |
| September 30, 2022 | -207.92M |
| June 30, 2022 | -195.19M |
| March 31, 2022 | -146.04M |
| December 31, 2021 | -66.53M |
| September 30, 2021 | -76.95M |
| June 30, 2021 | -61.43M |
| March 31, 2021 | -44.82M |
| December 31, 2020 | -21.92M |
| September 30, 2020 | 7.672M |
| June 30, 2020 | 18.58M |
| Date | Value |
|---|---|
| March 31, 2020 | 33.23M |
| December 31, 2019 | -9.405M |
| September 30, 2019 | -32.55M |
| June 30, 2019 | -82.63M |
| March 31, 2019 | -123.17M |
| December 31, 2018 | -94.54M |
| September 30, 2018 | -64.57M |
| June 30, 2018 | -42.85M |
| March 31, 2018 | -29.75M |
| December 31, 2017 | -33.19M |
| September 30, 2017 | -51.39M |
| June 30, 2017 | -63.53M |
| March 31, 2017 | -61.32M |
| December 31, 2016 | -71.32M |
| September 30, 2016 | -76.04M |
| June 30, 2016 | -80.43M |
| March 31, 2016 | -96.09M |
| December 31, 2015 | -84.61M |
| September 30, 2015 | -72.39M |
| June 30, 2015 | -68.60M |
| March 31, 2015 | -55.41M |
| December 31, 2014 | -72.30M |
| September 30, 2014 | -95.09M |
| June 30, 2014 | -120.84M |
| March 31, 2014 | -161.35M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Neurocrine Biosciences, Inc. | 839.70M |
| Alkermes Plc | 251.18M |
| Cellectis SA | -42.00M |
| Akari Therapeutics Plc | -10.74M |
| Liquidia Corp. | 167.71M |